Literature DB >> 8669891

Anti-human cytomegalovirus activity and toxicity of sulfonated anthraquinones and anthraquinone derivatives.

D L Barnard1, D W Fairbairn, K L O'Neill, T L Gage, R W Sidwell.   

Abstract

Sulfonated anthraquinones and other anthraquinone derivatives were evaluated for anti-human cytomegalovirus (HCMV) activity, cytotoxicity and genotoxicity. Acid blues 40 and 129, acid black 48, alizarin violet R and reactive blue 2 were the most active compounds having selective indices of greater than 30 and EC50 values of 4-30 microM. When tested against a clinical isolate, the 4 compounds were 2- to 5-fold less active. The antiviral activity was distinctly separate from the virucidal activity (> 1000 microM). The compounds were weakly toxic to either log phase or stationary cells in most of the following cytotoxicity assays: neutral red uptake assay, lactic acid dehydrogenase assay, trypan blue exclusion assay and radiolabeled macromolecular precursor uptake assays. Using a genotoxicity assay, the comet assay, only reactive blue 2 and acid black 48 were found to cause DNA strand breakage. This occurred at concentrations of 30 and 170 microM, respectively. These results suggest that these compounds could be a prototype for synthesizing even more effective HCMV-inhibitory anthraquinone derivatives.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8669891     DOI: 10.1016/0166-3542(95)00057-7

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  11 in total

1.  Virucidal agents in the eve of manorapid synergy.

Authors:  Angel S Galabov
Journal:  GMS Krankenhhyg Interdiszip       Date:  2007-09-13

2.  Elucidation of marine fungi derived anthraquinones as mycobacterial mycolic acid synthesis inhibitors: an in silico approach.

Authors:  Akanksha Sharma; M Hayatul Islam; Nida Fatima; Tarun K Upadhyay; M Kalim A Khan; Upendra N Dwivedi; Rolee Sharma
Journal:  Mol Biol Rep       Date:  2019-02-04       Impact factor: 2.316

3.  Alizarine derivatives as new dual inhibitors of the HIV-1 reverse transcriptase-associated DNA polymerase and RNase H activities effective also on the RNase H activity of non-nucleoside resistant reverse transcriptases.

Authors:  Francesca Esposito; Tatyana Kharlamova; Simona Distinto; Luca Zinzula; Yung-Chi Cheng; Ginger Dutschman; Giovanni Floris; Patrick Markt; Angela Corona; Enzo Tramontano
Journal:  FEBS J       Date:  2011-03-16       Impact factor: 5.542

Review 4.  Journey of anthraquinones as anticancer agents - a systematic review of recent literature.

Authors:  M Shaheer Malik; Reem I Alsantali; Rabab S Jassas; Abdulrahman A Alsimaree; Riyaz Syed; Meshari A Alsharif; Kulkarni Kalpana; Moataz Morad; Ismail I Althagafi; Saleh A Ahmed
Journal:  RSC Adv       Date:  2021-11-05       Impact factor: 4.036

5.  3-Allyl-1-{[3-(4-nitro-phen-yl)-4,5-dihydro-1,3-oxazol-5-yl]meth-yl}-1H-anthra[1,2-d]imidazole-2,6,11(3H)-trione.

Authors:  Zahra Afrakssou; Amal Haoudi; Frédéric Capet; Christian Rolando; Lahcen El Ammari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-05-07

6.  A WRKY transcription factor, PcWRKY33, from Polygonum cuspidatum reduces salt tolerance in transgenic Arabidopsis thaliana.

Authors:  Wenqi Bao; Xiaowei Wang; Mo Chen; Tuanyao Chai; Hong Wang
Journal:  Plant Cell Rep       Date:  2018-04-24       Impact factor: 4.570

7.  Anti-cytomegalovirus activity of the anthraquinone atanyl blue PRL.

Authors:  Zohaib Alam; Zainab Al-Mahdi; Yali Zhu; Zachary McKee; Deborah S Parris; Hardik I Parikh; Glen E Kellogg; Alison Kuchta; Michael A McVoy
Journal:  Antiviral Res       Date:  2014-12-10       Impact factor: 5.970

8.  Syntheses of 2-substituted 1-amino-4-bromoanthraquinones (bromaminic acid analogues) - precursors for dyes and drugs.

Authors:  Enas M Malik; Younis Baqi; Christa E Müller
Journal:  Beilstein J Org Chem       Date:  2015-11-26       Impact factor: 2.883

9.  Physcion-Matured Dendritic Cells Induce the Differentiation of Th1 Cells.

Authors:  Yun-Ho Hwang; Su-Jin Kim; Sung-Tae Yee
Journal:  Int J Mol Sci       Date:  2020-03-04       Impact factor: 5.923

10.  Screening and Evaluation of Novel Compounds against Hepatitis B Virus Polymerase Using Highly Purified Reverse Transcriptase Domain.

Authors:  Eriko Ohsaki; Keiji Ueda
Journal:  Viruses       Date:  2020-07-31       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.